✦ LIBER ✦

Tocilizumab reduces disease activity in rheumatoid arthritis

Book ID: 120856740
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 155 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414450-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

PMS30 Pharmacoeconomic Evaluation of Toc

PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

✍ F. Navarro sarabia; F.J. Blanco; J. Álvaro-Gracia; J. García Meijide; J. Poveda; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Golimumab reduces disease activity of rh

Golimumab reduces disease activity of rheumatoid arthritis for 1

✍ Hayashi, Masatoshi; Kobayakawa, Tomonori; Takanashi, Tetsuo; Yamazaki, Hideshi; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 207 KB

Tocilizumab radiates success in rheumato

Tocilizumab radiates success in rheumatoid arthritis

✍ Cheeseman, M 📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 197 KB

Tocilizumab an exciting OPTION in rheuma

Tocilizumab an exciting OPTION in rheumatoid arthritis

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 194 KB

Tocilizumab top of the class in rheumato

Tocilizumab top of the class in rheumatoid arthritis

✍ Sullivan, S 📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 195 KB